The intragastric administration of Lactobacillus lactis secreting interleukin-10 (IL-10) led to a substantial 50% reduction in colitis among DSS-treated mice and effectively prevented the onset of colitis in IL-10−/− mice (Steidler et al. 2000). This evidence concerns the gene IL10 and colitis.